Bellus Health Inc. – “Drugs are Big Business and Business is Booming in the Orphan Drug Space”

NEW YORK, NY / ACCESSWIRE / June 1, 2015 / BELLUS Health Inc. (TSX: BLU) today published a new blog post on The Chairman’s Blog, written by the Company’s Vice President, Business Development, Tony Matzouranis. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In today’s blog, Mr. Matzouranis discusses the tangible factors that have positively influenced the economics of orphan drug development. He states that with a projected total of orphan drug sales at $176B by 2020, it is little wonder why orphan drugs represent one of the most exciting areas of modern medicine for pharma, biotech, investors and patients. Read the full blog post from Mr. Matzouranis on TheChairmansBlog.com (http://www.thechairmansblog.com/bellus-health-inc/tony-matzouranis/drugs-big-business-business-booming-orphan-drug-space).

About Bellus Health Inc.

BELLUS Health is a drug development company focused on rare diseases. It has a portfolio of rare disease projects including KIACTA(TM) in Phase III for AA amyloidosis, KIACTA(TM) for sarcoidosis, clinical stage Shigamab(TM) for sHUS and a research-stage project for AL amyloidosis. The lead program KIACTA(TM) is currently in a Phase III Confirmatory Study for the treatment of AA amyloidosis, an orphan indication resulting in renal dysfunction that often leads to dialysis and death. KIACTA(TM) is partnered with global private equity firm Auven Therapeutics.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

SOURCE: TheChairmansBlog.com

ReleaseID: 429408